Table 2 Characteristics of the Patients at Baseline.

Male/Female (n)

6/5

Age (years), median (range)

57(9–84)

Disease duration, median (range)

1(1–62)

Severity

SAA (n)

Non-SAA (n)

6

5

Previous treatment regimens

Cyclosporine

ATG + cyclosporine

9

2

Baseline laboratory value, median (range)

ANC (10⁹/L)

Hemoglobin (g/L)

Reticulocyte (10⁹/L)

Platelet (10⁹/L)

0.94 (0.17–3.58)

61 (44–104)

1.7 (0.1–98.5)

24 (5–105)

PNH clones (n)

Yes

No

2

9

Chromosomal karyotype abnormality (n)

 + 8

1

MDS related mutation (n)

1

Number of cord blood infusions

One (n)

Two (n)

Three (n)

Four (n)

Five (n)

3

2

3

2

1